Drug-induced reduction in estimated glomerular filtration rate in patients with ALK-positive non-small cell lung cancer treated with the ALK inhibitor crizotinib

Estimating Equations for Glomerular Filtration Rate in the Era of Creatinine Standardization

(2013) Amy Earley et al.   ANNALS OF INTERNAL MEDICINE

Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer

(2012) Andrew J. Weickhardt et al.   CANCER

Proximal Tubular Secretion of Creatinine by Organic Cation Transporter OCT2 in Cancer Patients

(2012) G. Ciarimboli et al.   CLINICAL CANCER RESEARCH

Onco-Nephrology: Tumor Lysis Syndrome

(2012) F. P. Wilson et al.   Clinical Journal of the American Society of Nephrology

Severe Acute Interstitial Lung Disease After Crizotinib Therapy in a Patient With EML4-ALK–Positive Non–Small-Cell Lung Cancer

(2012) Akihiro Tamiya et al.   JOURNAL OF CLINICAL ONCOLOGY

Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer

(2012) Andrew J. Weickhardt et al.   Journal of Thoracic Oncology

Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study

(2012) D Ross Camidge et al.   LANCET ONCOLOGY

Treating ALK-positive lung cancer—early successes and future challenges

(2012) D. Ross Camidge et al.   Nature Reviews Clinical Oncology

Relative Performance of the MDRD and CKD-EPI Equations for Estimating Glomerular Filtration Rate among Patients with Varied Clinical Presentations

(2011) K. Murata et al.   Clinical Journal of the American Society of Nephrology

Asymptomatic Profound Sinus Bradycardia (Heart Rate ≤45) in Non-small Cell Lung Cancer Patients Treated with Crizotinib

(2011) Sai-Hong Ignatius Ou et al.   Journal of Thoracic Oncology

Better nephrology for mice—and man

(2010) Matthew D. Breyer et al.   KIDNEY INTERNATIONAL

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

(2010) Eunice L. Kwak et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tumor lysis syndrome after starting treatment with Gleevec in a patient with chronic myelogenous leukemia

(2009) A. Al-Kali et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS